TABLE3.

HBV Prevalence Characteristics and Vaccination Data

HBV Prevalence Characteristics (n, %)
Total tested for HBV	HBsAg+	DNA > 10,000 copies/mL	ALT > 40	HBeAg+
11,572	419 (3.6)	133 (31.7)	69 (16.5)	145 (34.6)
HBV DNA (IU/mL)	Total (n, %)
<2,000	286 (68.3)
2,000-20,000	24 (5.7)
>20,000	107 (25.5)
Not determined	2 (0.5)
HBV Vaccination*	Total (n, %)
Dose 1 (0 months)	9,253 (81.4)
Dose 2 (1 month)	7,176 (63.1)
Dose 3 (6 months)	5,176 (45.5)

^*Because of evolving stigma and patients infected with HBV becoming socially isolated, HBV vaccination was offered to all patients, including those with HBV viremia.

Abbreviation: HBeAg+, hepatitis B eantigen positive.